Dystonia Drugs Market Is Expected to Reach $1378.67 Million by 2031: Says AMR
08 mars 2023 20h30 HE
|
Allied Market Research
Portland, OR, March 08, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global dystonia drugs market was valued at $806.67 million in 2021, and is projected...
ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
01 févr. 2023 08h30 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
05 déc. 2022 08h30 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Pacemakers Market to Gain $10.9 Bn Revenue With 8.1% CAGR by 2027 | The Insight Partners
15 nov. 2022 08h16 HE
|
The Insight Partners
New York, Nov. 15, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners new market research study titled ‘Pacemakers Market Size, Share, Growth, Global Analysis and Forecasts by Product Type,...
RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition
08 août 2022 08h00 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Global Functional Electrical Stimulation Market to Grow with a CAGR of ~8.5% During 2022-2031; Market to Grow on Account of the Increasing Prevalence of Paralysis and Technological Advancement in the Healthcare Sector
22 juin 2022 08h23 HE
|
Research Nester
New York, June 22, 2022 (GLOBE NEWSWIRE) -- As Per World Health Organization, every year, between 250000 to 500000 persons suffer a spinal cord injury in the world. Functional electrical stimulation...
Ferrer Brings ALSton the Dragon to Life to Raise Awareness of ALS
21 juin 2022 04h00 HE
|
Ferrer
BARCELONA, Spain, June 21, 2022 (GLOBE NEWSWIRE) -- On Global Amyotrophic Lateral Sclerosis / Motor Neuron Disease (ALS/MND) Awareness Day on June 21, the Phantasticals campaign, run by Ferrer, the...
Enteral Feeding Devices Market worth USD 5.37 billion in 2028 with a CAGR of 6.38 %
15 juin 2022 10h53 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 15, 2022 (GLOBE NEWSWIRE) -- In 2020, the enteral feeding devices market accounted for up to USD 3.27 billion. It is predicted to expedite at a CAGR of 6.38% to USD...
IBN (InvestorBrandNetwork) Coverage Initiated for Silo Pharma Inc.
30 mars 2022 08h30 HE
|
Silo Pharma Inc.
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with...
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases
20 déc. 2021 07h00 HE
|
ARMGO
ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...